PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
62 hedge funds and large institutions have $276M invested in Poseida Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 10 closing their positions.
Holders
62
Holders Change
+6
Holders Change %
+10.71%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
26
Reduced
9
Closed
10
Calls
$131K
Puts
–
Net Calls
+$131K
Net Calls Change
+$133K
Top Buyers
1 |
1
BlackRock
New York
|
$27M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$13.7M |
3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$3.97M |
4 |
![]()
4
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$3.68M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$2.97M |